Acumen Pharmaceuticals Sees Significant Growth in Short Interest

요약

“Acumen Pharmaceuticals experienced a 50.1% increase in short interest during January”
“Short interest reached 900,167 shares with a days-to-cover ratio of 0.4 days”
“The company maintains a 'Moderate Buy' consensus rating with a target price of $6.80”

Profit ▼ Debt low Cash good Valuation high Drawdown neutral Recent recovery

Acumen Pharmaceuticals, 공매도 관심 급증 기록
Acumen Pharmaceuticals가 1월에 공매도 관심이 50.1% 증가
공매도 잔고가 90만 주에 달하며 커버 기간은 0.4일
회사는 '보통 매수' 컨센서스 등급과 6.80달러 목표가 유지

출처: Defense World
링크: https://www.defenseworld.net/2026/02/16/acumen-pharmaceuticals-inc-nasdaqabos-sees-significant-growth-in-short-interest.html

소셜 공유 미리보기(OG) 전용 페이지입니다.